Market Research Logo

Transcatheter Mitral Valves Implantation (TMVI) - Medical Devices Pipeline Assessment, 2018

Transcatheter Mitral Valves Implantation (TMVI) - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Transcatheter Mitral Valves Implantation (TMVI) - Medical Devices Pipeline Assessment, 2018 provides an overview of Transcatheter Mitral Valves Implantation (TMVI) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transcatheter Mitral Valves Implantation (TMVI) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Transcatheter Mitral Valves Implantation (TMVI) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transcatheter Mitral Valves Implantation (TMVI) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transcatheter Mitral Valves Implantation (TMVI) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Transcatheter Mitral Valves Implantation (TMVI) Overview
3 Products under Development
3.1 Transcatheter Mitral Valves Implantation (TMVI) - Pipeline Products by Stage of Development
3.2 Transcatheter Mitral Valves Implantation (TMVI) - Pipeline Products by Territory
3.3 Transcatheter Mitral Valves Implantation (TMVI) - Pipeline Products by Regulatory Path
3.4 Transcatheter Mitral Valves Implantation (TMVI) - Pipeline Products by Estimated Approval Date
3.5 Transcatheter Mitral Valves Implantation (TMVI) - Ongoing Clinical Trials
4 Transcatheter Mitral Valves Implantation (TMVI) - Pipeline Products under Development by Companies
4.1 Transcatheter Mitral Valves Implantation (TMVI) Companies - Pipeline Products by Stage of Development
4.2 Transcatheter Mitral Valves Implantation (TMVI) - Pipeline Products by Stage of Development
5 Transcatheter Mitral Valves Implantation (TMVI) Companies and Product Overview
5.1 4C Medical Technologies Inc Company Overview
5.1.1 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Annulon Company Overview
5.2.1 Annulon Pipeline Products & Ongoing Clinical Trials Overview
5.3 Cephea Valve Technologies, Inc. Company Overview
5.3.1 Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.4 Colibri Heart Valve, LLC Company Overview
5.4.1 Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.5 Daidalos Solutions BV Company Overview
5.5.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
5.6 Direct Flow Medical Inc (Inactive) Company Overview
5.6.1 Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.7 Edwards Lifesciences Corp Company Overview
5.7.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
5.8 Emory University Company Overview
5.8.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview
5.9 HighLife SAS Company Overview
5.9.1 HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview
5.10 LivaNova PLC Company Overview
5.10.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
5.11 Medtronic plc Company Overview
5.11.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Micro Interventional Devices, Inc. Company Overview
5.12.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.13 Mitralix Ltd. Company Overview
5.13.1 Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.14 MitrAssist Ltd. Company Overview
5.14.1 MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.15 MValve Technologies Ltd. Company Overview
5.15.1 MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.16 NaviGate Cardiac Structures, Inc. Company Overview
5.16.1 NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.17 Neovasc Inc Company Overview
5.17.1 Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 Sino Medical Sciences Technology Inc Company Overview
5.18.1 Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Trinity College Dublin Company Overview
5.19.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
5.20 University College London Company Overview
5.20.1 University College London Pipeline Products & Ongoing Clinical Trials Overview
5.21 Valtech Cardio Ltd Company Overview
5.21.1 Valtech Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.22 Venus MedTech Company Overview
5.22.1 Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview
6 Transcatheter Mitral Valves Implantation(TMVI)- Recent Developments
6.1 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value
6.2 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
6.3 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.4 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results
6.5 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.6 Mar 07, 2018: 4C Medical's Transcatheter Mitral Valve Technology Receives First Place in Cardiovascular Research Technologies 2018 Competition
6.7 Mar 01, 2018: 4C Medical's Novel Mitral Regurgitation Therapy to be Highlighted at CRT 2018 Meeting
6.8 Feb 28, 2018: First Oregonian receives artificial mitral heart valve without open-heart surgery
6.9 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results
6.10 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.11 Jan 08, 2018: Neovasc Reports Tiara's Clinical Case Load Accelerating
6.12 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
6.13 Dec 07, 2017: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
6.14 Dec 05, 2017: 4C Medical's Novel Transcatheter Mitral Valve Technology Awarded Best Technology Parade Presentation at ICI 2017
6.15 Dec 04, 2017: 4C Medical's Novel Transcatheter Mitral Valve Technology Presented at ICI 2017 Technology Parade
6.16 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results
6.17 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue
6.18 Nov 02, 2017: 4C Medical's Novel Transcatheter Mitral Valve Presented at TCT 2017 Shark Tank Innovation Competition
6.19 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report
6.20 Nov 01, 2017: Medtronic Unveils Strong Early Outcomes for the Intrepid Transcatheter Mitral Valve Replacement (TMVR) System
6.21 Oct 24, 2017: 4C Medicals Novel Mitral Regurgitation Therapy to be Presented at TCT 2017 Shark Tank Innovation Competition
6.22 Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results
6.23 Oct 23, 2017: First Patient Treated in Landmark Transcatheter Mitral Valve Replacement Pivotal Trial
6.24 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
6.25 Sep 24, 2017: Edwards Announces Key Events For PCR London Valves 2017
6.26 Sep 12, 2017: Neovasc Provides Tiara Clinical Update
6.27 Sep 01, 2017: Decision from Appeals Court upholds lower court decisions but denies injunction
6.28 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.29 Aug 03, 2017: 4C Medical's Novel Mitral Regurgitation Therapy Highlighted at CVI 2017 Innovation Summit
6.30 Jul 26, 2017: Edwards Lifesciences Reports Second Quarter Results
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Transcatheter Mitral Valves Implantation(TMVI) - Pipeline Products by Stage of Development
Table 2: Transcatheter Mitral Valves Implantation(TMVI) - Pipeline Products by Territory
Table 3: Transcatheter Mitral Valves Implantation(TMVI) - Pipeline Products by Regulatory Path
Table 4: Transcatheter Mitral Valves Implantation(TMVI) - Pipeline Products by Estimated Approval Date
Table 5: Transcatheter Mitral Valves Implantation(TMVI) - Ongoing Clinical Trials
Table 6: Transcatheter Mitral Valves Implantation(TMVI) Companies - Pipeline Products by Stage of Development
Table 7: Transcatheter Mitral Valves Implantation(TMVI) - Pipeline Products by Stage of Development
Table 8: 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: AltaValve - Product Status
Table 10: AltaValve - Product Description
Table 11: Annulon Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Mitral Valve Replacement Device - Product Status
Table 13: Mitral Valve Replacement Device - Product Description
Table 14: Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Mitral Valve Replacement Device - Product Status
Table 16: Mitral Valve Replacement Device - Product Description
Table 17: Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Mitral Valve - Product Status
Table 19: Mitral Valve - Product Description
Table 20: Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Sutureless Trans-Catheter Mitral Valve Replacement (TMVR) - Product Status
Table 22: Sutureless Trans-Catheter Mitral Valve Replacement (TMVR) - Product Description
Table 23: Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Direct Flow Medical Transcatheter Mitral Valve - Product Status
Table 25: Direct Flow Medical Transcatheter Mitral Valve - Product Description
Table 26: Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Cardiaq Mitral Valve - Product Status
Table 28: Cardiaq Mitral Valve - Product Description
Table 29: FORTIS Mitral Transcatheter Heart Valve - Product Status
Table 30: FORTIS Mitral Transcatheter Heart Valve - Product Description
Table 31: PASCAL Transcatheter Mitral Valve Repair System - Product Status
Table 32: PASCAL Transcatheter Mitral Valve Repair System - Product Description
Table 33: Sapien 3 Heart Valve - Mitral Annular Calcification - Product Status
Table 34: Sapien 3 Heart Valve - Mitral Annular Calcification - Product Description
Table 35: SAPIEN M3 - Product Status
Table 36: SAPIEN M3 - Product Description
Table 37: Second Generation Transapical Transcatheter Mitral Valve - Product Status
Table 38: Second Generation Transapical Transcatheter Mitral Valve - Product Description
Table 39: Edwards Lifesciences Corp - Ongoing Clinical Trials Overview
Table 40: FORTIS Mitral Transcatheter Heart Valve - Early Feasibility Study of the CardiAQ-Edwards Transcatheter Mitral Valve (TMV) System for the Treatment of Moderate to Severe Mitral Regurgitation
Table 41: Cardiaq Mitral Valve - Early Feasibility Study of the CardiAQ-Edwards Transcatheter Mitral Valve (TMV) System for the Treatment of Moderate to Severe Mitral Regurgitation
Table 42: Sapien 3 Heart Valve - Mitral Annular Calcification - Surgical Implantation of Transcatheter valve in Native Mitral Annular Calcification (SITRAL) Study
Table 43: Sapien 3 Heart Valve - Mitral Annular Calcification - The Safety and Feasibility of the SAPIEN XT Transcatheter Heart Valve with NovaFlex and Ascendra Delivery Systems and SAPIEN 3 with Commander Delivery System in Patients with Symptomatic Severe Calcific Mitral Valve Disease with Severe Mitral Annular Calcification and Patients with Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Table 44: PASCAL Transcatheter Mitral Valve Repair System - CE Mark Study of PASCAL Transcatheter Mitral Valve Repair System
Table 45: PASCAL Transcatheter Mitral Valve Repair System - The CLASP Study Edwards PASCAL TranScatheter Mitral Valve Repair System Study
Table 46: Emory University Pipeline Products & Ongoing Clinical Trials Overview
Table 47: MitraCath - Product Status
Table 48: MitraCath - Product Description
Table 49: HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Transcatheter Mitral Valve Replacement System - Product Status
Table 51: Transcatheter Mitral Valve Replacement System - Product Description
Table 52: HighLife SAS - Ongoing Clinical Trials Overview
Table 53: Transcatheter Mitral Valve Replacement System - HighLife Transcatheter Mitral Valve Replacement System for Severe Mitral Regurgitation in Patients at High Surgical Risk
Table 54: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Caisson TMVR System - Product Status
Table 56: Caisson TMVR System - Product Description
Table 57: LivaNova PLC - Ongoing Clinical Trials Overview
Table 58: Caisson TMVR System - Percutaneous Mitral Valve Replacement Evaluation Utilizing IDE Early Feasibility Study (PRELUDE)
Table 59: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Intrepid Transcatheter Mitral Valve Replacement - Product Status
Table 61: Intrepid Transcatheter Mitral Valve Replacement - Product Description
Table 62: TCV - Mitral - Product Status
Table 63: TCV - Mitral - Product Description
Table 64: Twelve Transcatheter Mitral Valve Replacement System - Product Status
Table 65: Twelve Transcatheter Mitral Valve Replacement System - Product Description
Table 66: Medtronic plc - Ongoing Clinical Trials Overview
Table 67: Twelve Transcatheter Mitral Valve Replacement System - Evaluation of Safety and Performance of the Twelve Transcatheter Mitral Valve Replacement System in Patients with Severe, Symptomatic Mitral Regurgitation
Table 68: Intrepid Transcatheter Mitral Valve Replacement - Transcatheter Mitral Valve Replacement with the Medtronic Intrepid TMVR System in Patients with Severe Symptomatic Mitral Regurgitation - APOLLO Trial
Table 69: Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 70: Endovalve - Product Status
Table 71: Endovalve - Product Description
Table 72: Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 73: MAESTRO - Product Status
Table 74: MAESTRO - Product Description
Table 75: MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 76: MitrAssist Valve - Product Status
Table 77: MitrAssist Valve - Product Description
Table 78: MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 79: MValve Docking System - Product Status
Table 80: MValve Docking System - Product Description
Table 81: MValve Technologies Ltd. - Ongoing Clinical Trials Overview
Table 82: MValve Docking System - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
Table 83: NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 84: Navi Mitral Valved Stent - Product Status
Table 85: Navi Mitral Valved Stent - Product Description
Table 86: NaviGate Cardiac Structures, Inc. - Ongoing Clinical Trials Overview
Table 87: Navi Mitral Valved Stent - Navi Valved Stent for Correction of Severe Functional Mitral Regurgitation (FMR)
Table 88: Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 89: Tiara Transcatheter Mitral Valve - Product Status
Table 90: Tiara Transcatheter Mitral Valve - Product Description
Table 91: Neovasc Inc - Ongoing Clinical Trials Overview
1.2 List of Figures
Figure 1: Transcatheter Mitral Valves Implantation(TMVI) - Pipeline Products by Stage of Development
Figure 2: Transcatheter Mitral Valves Implantation(TMVI) - Pipeline Products by Territory
Figure 3: Transcatheter Mitral Valves Implantation(TMVI) - Pipeline Products by Regulatory Path
Figure 4: Transcatheter Mitral Valves Implantation(TMVI) - Pipeline Products by Estimated Approval Date
Figure 5: Transcatheter Mitral Valves Implantation(TMVI) - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report